Tilray Brands Files 2024 10-K: Assets $1.198B, Liabilities $980M

Ticker: TLRY · Form: 10-K · Filed: 2024-07-30T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, financials, cannabis

TL;DR

Tilray's FY24 10-K is in: $1.198B assets, $980M liabilities. Cannabis sector still volatile.

AI Summary

Tilray Brands, Inc. filed its 10-K for the fiscal year ending May 31, 2024, reporting total assets of $1.198 billion and total liabilities of $980 million. The company's filing indicates a significant focus on its medicinal chemicals and botanical products segment. Key financial figures and operational details for the fiscal year are outlined in the report.

Why It Matters

This 10-K filing provides a comprehensive overview of Tilray Brands' financial health and operational performance for the fiscal year 2024, crucial for investors and stakeholders to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — The cannabis industry is subject to significant regulatory and market volatility, which can impact Tilray Brands' financial performance and stock price.

Key Numbers

Key Players & Entities

FAQ

What were Tilray Brands' total assets as of May 31, 2024?

Tilray Brands reported total assets of $1,198,000,000 as of May 31, 2024.

What were Tilray Brands' total liabilities as of May 31, 2024?

Tilray Brands reported total liabilities of $980,000,000 as of May 31, 2024.

What is Tilray Brands' Standard Industrial Classification code?

Tilray Brands' Standard Industrial Classification code is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].

What was the reported revenue for the fiscal year ending May 31, 2024?

The reported revenue for the fiscal year ending May 31, 2024, was $831,925,373.

What was the net income for the fiscal year ending May 31, 2024?

The net income for the fiscal year ending May 31, 2024, was $656,655,455.

From the Filing

0001437749-24-023774.txt : 20240730 0001437749-24-023774.hdr.sgml : 20240730 20240729185952 ACCESSION NUMBER: 0001437749-24-023774 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 154 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 241153979 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 10-K 1 tlry20240531c_10k.htm FORM 10-K tlry20240531c_10k.htm 0001731348 Tilray Brands, Inc. false --05-31 FY 2024 0.0001 0.0001 1,198,000,000 980,000,000 831,925,373 831,925,373 656,655,455 656,655,455 0.0001 0.0001 10,000,000 10,000,000 0 0 0 0 3 0 0 20 30 3 25 14 16 90 15 25 5 4 0 0 0 http://fasb.org/us-gaap/2024#AssetImpairmentCharges http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityCurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent http://www.tilray.com/20240531#OperatingAndFinanceLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2024#AssetImpairmentCharges 0 0 100 8 0 3.50 0 0 60 0 0 0 0 0 0 0 0 0 0 0 0 2018 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023 2019 2020 2021 2022 2023 2020 2021 2022 2023 1,000 0 2 7,000 500 7,438 7,500 7,000 500 66,000 66,000 3 3 10 10 November 30, 2025 November 30, 2025 25,000 25,000 1.00 1.00 5 5 15 15 181 181 July 31, 2033 July 31, 2033 25,000 25,000 1.00 1.00 5 5 15 15 196 196 July 31, 2033 July 31, 2033 1,250 1,250 1.50 1.50 5 5 10 10 12 12 August 31, 2026 August 31, 2026 3,750 3,750 1.50 1.50 5 5 20 20 23 23 August 31, 2026 August 31, 2026 5,000 5,000 2.15 2.15 5 5 250 250 December 31, 2023 December 31, 2023 1,200 1,200 4.26 4.26 1 1 100 100 December 31, 2023 December 31, 2023 1,500 1,500 2.00 2.00 5 5 94 94 April 30, 2025 April 30, 2025 3,500 3,500 4.59 4.59 5 5 66 66 August 31, 2028 August 31, 2028 22,635 22,635 1.5 1.5 10 10 57 57 October 31, 2030 October 31, 2030 90,000 90,000 5 5 875 875 1,750 1,750 June 30, 2028 June 30, 2028 66,000 66,000 25,000 25,000 1,250 3,750 1,500 3,500 June 30, 2028 5.20 5.20 5.25 5.25 5.00 5.00 4.00 4.00 0 0 5.20 5.20 5.25 5.25 5.00 5.00 6,209,000 6,209,000 5.95 1 1 831,925,373 0 0 656,655,455 0 0 500,000 1,000,000 10 0 0 0 0 0 0 20,000 0 6,641 1,073 7,714 4 0 0 0 false false false false Included in movements for the period is the total movements for foreign exchange, additions to the provisions and utilization of the credit loss provision and allowance for doubtful accounts. 0001731348 2023-06-01 2024-05-31 iso4217:USD 0001731348 2023-11-30 xbrli:shares 0001731348 2024-07-25 thunderdome:item 0001731348 2024-05-31 0001731348 2023-05-31 iso4217:USD xbrli:shares 0001731348 2022-06-01 2023-05-31 0001731348 2021-06-01 2022-05-31 0001731348 tlry:CommonStockAndPreferredStockMember 2021-05-31 0001731348 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001731348 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-31 0001731348 us-gaap:RetainedEarningsMember 2021-05-31 0001731348 us-gaap:NoncontrollingInterestMember 2021-05-31 0001731348 2021-05-31 0001731348 tlry:CommonStockAndPreferre

View on Read The Filing